• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Ampio Pharmaceuticals Inc

+ Add to Watchlist


3.992 EUR 0.0000.00%

As of 02:16:13 ET on 04/17/2014.

Snapshot for Ampio Pharmaceuticals Inc (APH)

Open: 3.951 Day's Range: 3.951 - 3.992 Volume: 0
Previous Close: 3.992 52wk Range: 3.590 - 7.606 1-Yr Rtn: +6.57%

Stock Chart for APH

No chart data available.
  • APH:GR 3.992
  • 1D
  • 1M
  • 1Y
Interactive APH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.7100
Est. PEG Ratio -
Market Cap (M EUR) 202.16
Shares Outstanding (M) 50.64
30 Day Average Volume 17
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for APH

Ampio Pharmaceuticals, Inc. researches and develops drugs. The Company researches treatments for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The Company's product pipeline includes some new uses for previously approved drugs.

Michael Macaluso JrChairman/CEOMark D McGregorChief Financial Officer
Joshua R Disbrow "Josh"Chief Operating OfficerVaughan L CliftChief Regulatory Affairs Ofcr
More Company Profile & Key Executives for APH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil